Abstract：Electrolytic process has the highest energy consumption in copper powder production, and process conditions have an important impact on electrolytic energy consumption, which needs in-depth research and optimization. Copper powder was prepared by electrolysis. The effects of interelectrode gap, Cu 2＋ concentration, sulfuric acid concentration, electrolyte temperature, current density and scraping period on cell voltage, current efficiency and DC power consumption in electrolytic copper powder process were studied. The results show that increasing Cu 2＋concentration, electrolyte temperature and powder scraping period are conducive to reducing cell voltage and improving current efficiency, thus reducing DC power consumption. The cell voltage, current efficiency and DC power consumption of electrolytic copper powder increase when the interelectrode gap is increased. However, when the concentration of sulfuric acid is increased, the cell voltage, current efficiency and DC power consumption of electrolytic copper powder are reduced. When the current density is increased, the cell voltage of electrolytic copper powder is significantly increased and the current efficiency is slightly decreased, resulting in a significant increase in DC power consumption. The optimum process parameters of electrolytic copper powder are: interelectrode gap 20-40 mm, Cu 2＋ concentration 10-15 g/L, sulfuric acid concentration 150 g/L, electrolyte temperature 40-50 ℃, current density 1 500 A/m2, and powder scraping period 45 min.
王宏丹，夏文堂，任兵芝，孙亚峰，邓佑明. 工艺条件对电解铜粉过程能耗的影响规律研究[J]. 粉末冶金工业, 2019, 29(04): 12-16.
WANG Hong-dan, XIA Wen-tang, REN Bing-zhi, SUN Ya-feng, DENG You-ming. Study on the influence of process conditions on energy consumption in electrolytic copper powder process. Powder Metallurgy Industry, 2019, 29(04): 12-16.
[1] Benedet JL, Bender H, Jones H 3rd, et al. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancersFIGO Committee on Gynecologic Oncology[J].Int J Gynaecol Obstet.2000,70(2):209-262
[2] Oehler MK, Wain GV, Brand A. Gynaecological malignancies in pregnancy: a review[J].Aust N Z J Obstet Gynaecol.2003, 43(6):414-420
[3] Sayedur Rahman M, Al-Sibai MH, Rahman J, et al. Ovarian carcinoma associated with pregnancy. A review of9 cases[J]. Acta Obstet Gynecol Scand, 2002, 81(3):260-264.
[4] Machado F, Vegas C, Leon J, et al. Ovarian cancer during pregnancy: analysis of 15 cases[J].Gynecol Oncol.2007, 105(2):446-450
[5] 付晨薇, 杨佳欣, 刘俊涛, 等. 剖宫产术中附件包块手术病例分析[J]. 中华围产医学杂志, 2007, 10(5):336-338.
[6] Behtash N, Karimi Zarchi M, Modares Gilani M, et al. Ovarian carcinoma associated with pregnancy: a clinicopathologic analysis of 23 cases and review of the literature[J].BMC Pregnancy Childbirth.2008, 8:3-
[7] Palmer J, Vatish M, Tidy J. Epithelial ovarian cancer in pregnancy: a review of the literature[J].BJOG.2009, 116(4):480-491
[8] Leiserowitz GS, Xing G, Cress R, et al. Adnexal masses in pregnancy: how often are they malignant[J].Gynecol Oncol.2006, 101(2):315-321
[9] Modares Gilani M, Karimi Zarchi M, Behtash N, et al. Preservation of pregnancy in a patient with advanced ovarian caner at 20 weeks of gestation: case report and literature review[J].Int J Gynecol Cancer.2007, 17(5):1140-1143 [10] Zemlickis D, Lishner M, Degendorfer P, et al. Fetal outcome after in utero exposure to cancer chemotherapy[J].Arch Intern Med.1992, 152(3):573-576
[11] Kwon YS, Mok JE, Lim KT, et al. Ovarian cancer during pregnancy: clinical and pregnancy outcome[J].J Korean Med Sci.2010, 25(2):230-234
[12] Jameel A, Jamil SN. Safety of cytotoxic chemotherapy during pregnancy[J]. J pak Med Assoc, 2007, 57(9):449-452.
[13] Ishioka S, Hayashi T, Endo T, et al. Advanced epithelial ovarian carcinoma during pregnancy[J].Int J Clin Oncol.2007, 12(2):375-378
2019, Vol. 29 
